Company Filing History:
Years Active: 2023
Title: An Qin - Innovator in Biological Medicine
Introduction
An Qin is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biological medicine, particularly in the treatment of bone-related diseases. His innovative work has garnered attention for its potential applications in clinical practice.
Latest Patents
An Qin holds a patent for the "Use of recombinant human secretory DDRGK1." This patent outlines the use of a recombinant human secretory DDRGK1 in the preparation of biological medicines aimed at treating intervertebral disc degeneration, fractures, or bone defects. The experiments conducted demonstrate that this recombinant protein can provide a promising direction for the treatment of various bone-related conditions. The scientific evidence supporting this innovation expands the potential applications of recombinant human secretory DDRGK1 in clinical settings.
Career Highlights
An Qin is affiliated with Shanghai Jiao Tong University, where he continues to advance his research in biological medicine. His work has not only contributed to the academic community but also holds the potential for real-world applications that can benefit patients suffering from bone-related ailments.
Collaborations
An Qin collaborates with esteemed colleagues, including Tangjun Zhou and Ying Xia, who contribute to his research endeavors. Their combined expertise enhances the quality and impact of their work in the field of biological medicine.
Conclusion
An Qin's innovative contributions to the field of biological medicine, particularly through his patent on recombinant human secretory DDRGK1, highlight his role as a key inventor in addressing bone-related diseases. His work at Shanghai Jiao Tong University and collaborations with fellow researchers further solidify his impact in this vital area of healthcare.